A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer

Clinical trial NCT07691489 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07691489
Sponsor: Memorial Sloan Kettering Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Adenocarcinoma of the Colon Adenocarcinoma of the Rectum

Start date: 2026-08-01
Primary completion: 2029-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.